According to AN2 Therapeutics's latest financial reports the company's current EPS (TTM) is -โน239.35. In 2022 the company made an earnings per share (EPS) of -โน401.90 a decrease over its 2021 EPS that were of -โน157.74.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน229.89 | -42.8% |
2022 | -โน401.90 | 154.79% |
2021 | -โน157.74 |